Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spirit Scientific CoROCO:7790 +0.10%19 5-Year Yield-on-Cost % is 1.20 as of Aug. 15, 2026, which is 900% above its 10-year median of 0.12. GuruFocus rates ROCO:7790 with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 150 Biotechnology companies, Spirit Scientific Co ranks worse than 57.33% on this metric.
Spirit Scientific Co's yield on cost for the quarter that ended in Dec. 2025 was 1.20.
The historical rank and industry rank for Spirit Scientific Co's 5-Year Yield-on-Cost % or its related term are showing as below:
ROCO:7790'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.09 Med: 0.12 Max: 1.21
Current: 1.2
During the past 5 years, Spirit Scientific Co's highest Yield on Cost was 1.21. The lowest was 0.09. And the median was 0.12.
ROCO:7790's 5-Year Yield-on-Cost % is ranked worse than 57.33% of 150
companies
in the Biotechnology industry
Industry Median: 1.6
vs ROCO:7790: 1.20
Spirit Scientific Co (ROCO:7790) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Spirit Scientific Co 5-Year Yield-on-Cost % Related Terms
ROCO:7790 vs VRTX, REGN, RVMD: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Spirit Scientific Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spirit Scientific Co 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Spirit Scientific Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Spirit Scientific Co's 5-Year Yield-on-Cost % falls into.
Spirit Scientific Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Spirit Scientific Co (ROCO:7790) has a 5-Year Yield-on-Cost % of 1.20 as of Aug. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Spirit Scientific Co and its competitors. This is 900% above median its historical median of 0.12. Over the past decade, Spirit Scientific Co's 5-Year Yield-on-Cost % has ranged from 0.09 to 1.21. According to the industry distribution chart, Spirit Scientific Co ranks #86 out of 150 companies in the Biotechnology industry, placing it in the top 57.3%.
Is Spirit Scientific Co's 5-Year Yield-on-Cost % too high?
Spirit Scientific Co's current 5-Year Yield-on-Cost % of 1.20 is 900% above median its 10-year median of 0.12. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 1.21. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.60. Spirit Scientific Co's value of 1.20 is 25% below this industry median. Based on the distribution chart, Spirit Scientific Co ranks #86 out of 150 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Spirit Scientific Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Spirit Scientific Co's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Spirit Scientific Co ranks #86 out of 150 companies for 5-Year Yield-on-Cost %. This places Spirit Scientific Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.60. Spirit Scientific Co's value of 1.20 is 25% below this benchmark. Historically, Spirit Scientific Co's own 5-Year Yield-on-Cost % has ranged from 0.09 to 1.21 over the past decade. While the company's 10-year median is 0.12 vs. the industry median of 1.60, Spirit Scientific Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.60, based on 150 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spirit Scientific Co's current 5-Year Yield-on-Cost % of 1.20 is 25% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Spirit Scientific Co and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spirit Scientific Co's current 5-Year Yield-on-Cost % is 1.20, which is 900% above median its own 10-year median of 0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spirit Scientific Co stock overvalued right now?
Spirit Scientific Co (ROCO:7790) has a current 5-Year Yield-on-Cost % of 1.20. The current 5-Year Yield-on-Cost % is 1.20, which is 900% above median its 10-year median of 0.12 and 25% below the Biotechnology industry median of 1.60. Spirit Scientific Co's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Spirit Scientific Co (ROCO:7790), the current 5-Year Yield-on-Cost % is 1.20 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Spirit Scientific Co Ltd is engaged in precision regenerative medicine, specializing in platelet cryocrystallization technology and Bio Material Lyophilized Technology (BMLT). The company provides solutions for extracting high-concentration platelet growth factors, enabling safe, flexible, and long-term storage therapies. Spirit Biotech delivers cutting-edge autologous healing reagent preparation services, along with OEM and ODM models. With a focus on unmet medical needs, the company transforms patented technologies into scalable solutions, advancing the future of regenerative healthcare.
19GF Score
Get the complete analysis for ROCO:7790
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7790 has been successfully added to your 
